Showing 1 - 6 results of 6 for search 'Hiroo Ishida', query time: 0.04s Refine Results
  1. 1
    Associations of HLA‐C*01:02 and HLA‐B*46:01 with regorafenib‐induced erythema multiforme in Japanese patients with metastatic colorectal cancer

    Associations of HLA‐C*01:02 and HLA‐B*46:01 with regorafenib‐induced erythema multiforme in Japanese patients with metastatic colorectal cancer by Ken‐ichi Fujita, Natsumi Matsumoto, Remi Murase, Kosuke Takeshima, Hiroo Ishida, Yutaro Kubota

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Characteristics of miRNA-SNPs in healthy Japanese subjects and non-small cell lung cancer, colorectal cancer, and soft tissue sarcoma patients

    Characteristics of miRNA-SNPs in healthy Japanese subjects and non-small cell lung cancer, colorectal cancer, and soft tissue sarcoma patients by Koki Katayama, Shimon Nakashima, Hiroo Ishida, Yutaro Kubota, Masataka Nakano, Tatsuki Fukami, Yasutsuna Sasaki, Ken-ichi Fujita, Miki Nakajima

    Published 2021-09-01
    Get full text
    Article
  3. 3
    Treatment of oral cancers during pregnancy: a case-based discussion

    Treatment of oral cancers during pregnancy: a case-based discussion by Kiyoshi Sato, Hiroaki Shimamoto, Yumi Mochizuki, Hideaki Hirai, Hirofumi Tomioka, Risa Shimizu, Eriko Marukawa, Haruhisa Fukayama, Ryoichi Yoshimura, Hiroo Ishida, Hiroyuki Harada

    Published 2019-02-01
    Get full text
    Article
  4. 4
    Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy

    Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor ant... by Takuhiro Yamaguchi, Tempei Miyaji, Hirotoshi Iihara, Yasushi Ohno, Takako Eguchi Nakajima, Chikatoshi Katada, Takashi Kawaguchi, Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura, Honda Kazunori, Yusuke Inada, Hitoshi Arioka, Hajime Morita, Naoya Hida, Mitsuhiro Sugawara, Shuichi Nawata, Hiroo Ishida, Takashi Tsuda

    Published 2020-12-01
    Get full text
    Article
  5. 5
    High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.

    High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. by Ryotaro Ohkuma, Erica Yada, Shumpei Ishikawa, Daisuke Komura, Hidenobu Ishizaki, Koji Tamada, Yutaro Kubota, Kazuyuki Hamada, Hiroo Ishida, Yuya Hirasawa, Hirotsugu Ariizumi, Etsuko Satoh, Midori Shida, Makoto Watanabe, Rie Onoue, Kiyohiro Ando, Junji Tsurutani, Kiyoshi Yoshimura, Takehiko Yokobori, Tetsuro Sasada, Takeshi Aoki, Masahiko Murakami, Tomoko Norose, Nobuyuki Ohike, Masafumi Takimoto, Masahiko Izumizaki, Shinichi Kobayashi, Takuya Tsunoda, Satoshi Wada

    Published 2020-01-01
    Get full text
    Article
  6. 6
    A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis

    A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI s... by Hisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi, Tomonori Makiguchi, Megumi Inaba, Takeshi Honda, Junya Nakamura, Koji Inoue, Takayuki Kishikawa, Masanao Nakashima, Keiichi Fujiwara, Tadashi Kohyama, Hiroo Ishida, Shoichi Kuyama, Naoki Miyazawa, Tomomi Nakamura, Hiroshi Miyawaki, Naohiro Oda, Nobuhisa Ishikawa, Ryotaro Morinaga, Kei Kusaka, Nobukazu Fujimoto, Yasushi Fukuda, Masayuki Yasugi, Takeshi Tsuda, Sunao Ushijima, Kazuhiko Shibata, Takuo Shibayama, Akihiro Bessho, Kyoichi Kaira, Kenshiro Shiraishi, Noriyuki Matsutani, Nobuhiko Seki

    Published 2022-12-01
    Get full text
    Article

Search Tools: